(GEN) Gen Digital - Overview
Sector: Technology | Industry: Software - Infrastructure | Exchange: NASDAQ (USA) | Market Cap: 11.329m USD | Total Return: -24.9% in 12m
Industry Rotation: -27.5
Avg Turnover: 140M USD
Peers RS (IBD): 47.3
EPS Trend: 95.9%
Qual. Beats: 0
Rev. Trend: 90.6%
Qual. Beats: 0
Warnings
Altman Z'' 0.33 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Gen Digital Inc. (GEN) provides cybersecurity solutions to individuals, families, and small businesses. Its offerings include security, performance management, identity protection, and online privacy. This business model relies on recurring subscriptions for digital protection services.
The company markets its products under several brands, including Norton, Avast, LifeLock, and Avira. The cybersecurity sector is characterized by continuous threats and evolving defense mechanisms.
Formerly NortonLifeLock Inc., the company rebranded in November 2022. Gen Digital Inc. was founded in 1982 and is headquartered in Tempe, Arizona.
For more detailed financial and operational data, ValueRay offers comprehensive company profiles.
- Subscription renewals drive recurring revenue growth
- Cybersecurity threat landscape increases demand for protection
- Acquisition strategy expands product portfolio and market share
- Data privacy regulations impact product development and compliance costs
- Inflationary pressures affect consumer discretionary spending on subscriptions
| Net Income: 603.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -4.29 > 1.0 |
| NWC/Revenue: -30.36% < 20% (prev -62.80%; Δ 32.44% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.54b > Net Income 603.0m |
| Net Debt (7.79b) to EBITDA (2.18b): 3.57 < 3 |
| Current Ratio: 0.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (622.0m) vs 12m ago -0.16% < -2% |
| Gross Margin: 77.68% > 18% (prev 0.80%; Δ 7.69k% > 0.5%) |
| Asset Turnover: 30.31% > 50% (prev 25.33%; Δ 4.97% > 0%) |
| Interest Coverage Ratio: 2.97 > 6 (EBITDA TTM 2.18b / Interest Expense TTM 574.0m) |
| A: -0.09 (Total Current Assets 1.25b - Total Current Liabilities 2.69b) / Total Assets 15.83b |
| B: 0.00 (Retained Earnings 32.0m / Total Assets 15.83b) |
| C: 0.11 (EBIT TTM 1.70b / Avg Total Assets 15.60b) |
| D: 0.17 (Book Value of Equity 2.33b / Total Liabilities 13.50b) |
| Altman-Z'' Score: 0.33 = B |
| DSRI: 1.81 (Receivables 361.0m/164.0m, Revenue 4.73b/3.89b) |
| GMI: 1.03 (GM 77.68% / 80.29%) |
| AQI: 1.01 (AQ_t 0.92 / AQ_t-1 0.91) |
| SGI: 1.21 (Revenue 4.73b / 3.89b) |
| TATA: -0.06 (NI 603.0m - CFO 1.54b) / TA 15.83b) |
| Beneish M-Score: -2.23 (Cap -4..+1) = BBB |
Over the past week, the price has changed by -7.64%, over one month by -17.86%, over three months by -32.81% and over the past year by -24.89%.
- StrongBuy: 4
- Buy: 1
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 31.2 | 74.3% |
P/E Forward = 6.5445
P/S = 2.3967
P/B = 5.0307
P/EG = 0.4742
Revenue TTM = 4.73b USD
EBIT TTM = 1.70b USD
EBITDA TTM = 2.18b USD
Long Term Debt = 8.17b USD (from longTermDebt, last quarter)
Short Term Debt = 240.0m USD (from shortTermDebt, last quarter)
Debt = 8.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.79b USD (from netDebt column, last quarter)
Enterprise Value = 19.12b USD (11.33b + Debt 8.41b - CCE 619.0m)
Interest Coverage Ratio = 2.97 (Ebit TTM 1.70b / Interest Expense TTM 574.0m)
EV/FCF = 12.60x (Enterprise Value 19.12b / FCF TTM 1.52b)
FCF Yield = 7.94% (FCF TTM 1.52b / Enterprise Value 19.12b)
FCF Margin = 32.09% (FCF TTM 1.52b / Revenue TTM 4.73b)
Net Margin = 12.76% (Net Income TTM 603.0m / Revenue TTM 4.73b)
Gross Margin = 77.68% ((Revenue TTM 4.73b - Cost of Revenue TTM 1.05b) / Revenue TTM)
Gross Margin QoQ = 73.95% (prev 78.20%)
Tobins Q-Ratio = 1.21 (Enterprise Value 19.12b / Total Assets 15.83b)
Interest Expense / Debt = 1.63% (Interest Expense 137.0m / Debt 8.41b)
Taxrate = 37.86% (117.0m / 309.0m)
NOPAT = 1.06b (EBIT 1.70b * (1 - 37.86%))
Current Ratio = 0.47 (Total Current Assets 1.25b / Total Current Liabilities 2.69b)
Debt / Equity = 3.61 (Debt 8.41b / totalStockholderEquity, last quarter 2.33b)
Debt / EBITDA = 3.57 (Net Debt 7.79b / EBITDA 2.18b)
Debt / FCF = 5.13 (Net Debt 7.79b / FCF TTM 1.52b)
Total Stockholder Equity = 2.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.87% (Net Income 603.0m / Total Assets 15.83b)
RoE = 25.60% (Net Income TTM 603.0m / Total Stockholder Equity 2.36b)
RoCE = 16.18% (EBIT 1.70b / Capital Employed (Equity 2.36b + L.T.Debt 8.17b))
RoIC = 10.17% (NOPAT 1.06b / Invested Capital 10.40b)
WACC = 6.03% (E(11.33b)/V(19.74b) * Re(9.76%) + D(8.41b)/V(19.74b) * Rd(1.63%) * (1-Tc(0.38)))
Discount Rate = 9.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.80%
[DCF] Terminal Value 86.54% ; FCFF base≈1.76b ; Y1≈1.83b ; Y5≈2.08b
[DCF] Fair Price = 87.58 (EV 60.83b - Net Debt 7.79b = Equity 53.05b / Shares 605.7m; r=6.03% [WACC]; 5y FCF grow 3.71% → 3.0% )
EPS Correlation: 95.94 | EPS CAGR: 9.21% | SUE: 0.69 | # QB: 0
Revenue Correlation: 90.64 | Revenue CAGR: 15.77% | SUE: 0.50 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.68 | Chg7d=+0.000 | Chg30d=+0.002 | Revisions Net=+0 | Analysts=7
EPS next Year (2027-03-31): EPS=2.87 | Chg7d=+0.000 | Chg30d=-0.002 | Revisions Net=+5 | Growth EPS=+12.7% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: +0.00 (2 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.5% (Discount Rate 9.8% - Earnings Yield 5.3%)
[Growth] Growth Spread = -3.5% (Analyst 1.0% - Implied 4.5%)